Exane BNP Paribas upgraded AT&T to Outperform from Neutral with a $28.50 price target Maximize Your Portfolio with Data Driven ...
Exane BNP Paribas analyst Victor Floch upgraded Genmab (GMAB) to Neutral from Underperform with a DKK 1,500 price target. The shares trade at a ...
Exane analyst Victor Floch upgraded Genmab (NASDAQ:GMAB) A/S shares from Underperform to Neutral, adjusting the price target ...
5d
Fintel on MSNExane BNP Paribas Upgrades Array Technologies (ARRY)Fintel reports that on February 6, 2025, Exane BNP Paribas upgraded their outlook for Array Technologies (NasdaqGM:ARRY) from ...
Foreign institutional investors hold significant Indian equities, posing market risks. Domestic investments grow as a ...
Exane BNP Paribas upgraded Adobe Inc. (NASDAQ:ADBE) to Neutral from Underperform and raised the stock's price target to $425. The analyst views better risks and rewards consideration on Adobe for ...
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Fintel reports that on January 5, 2025, BNP PARIBAS EXANE downgraded their outlook for ISS A (LSE:0QRS) from Outperform to Neutral. As of December 23, 2024, the average one-year price target for ...
Fintel reports that on February 6, 2025, Exane BNP Paribas upgraded their outlook for Array Technologies (NasdaqGM:ARRY) from Underperform to Neutral. As of January 29, 2025, the average one-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results